Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.
Punglia
Rinaa S
RS
Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Hassett
Michael J
MJ
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008279:Magnetic Resonance Imaging; D008403:Mass Screening / Q000379:methods*; D015233:Models, Statistical; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D017741:Survivors / Q000706:statistics & numerical data*; D013997:Time Factors; D016896:Treatment Outcome